Tocqueville Asset Management L.P. Arrowhead Pharmaceuticals, Inc. Transaction History

Tocqueville Asset Management L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 31, 2019	SELL	$17.43 - $28.82 $214,389 - $354,486	-12,300 Closed	0 $0
Q1 2019 Apr 30, 2019	SELL	$12.05 - $20.18 $86,760 - $145,296	-7,200 Reduced 36.92%	12,300 $226,000
Q4 2018 Feb 08, 2019	BUY	$10.74 - $19.7 $209,430 - $384,150	19,500 New	19,500 $242,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.